IVF

Showing 2 posts of 2 posts found.

Ferring strengthens evidence for flexible dosing of follitropin delta in IVF

July 3, 2025
Research and Development Ferring Pharmaceuticals, IVF, Reproductive health, clinical trial, fertility treatment, in vitro fertilisation, ovarian hyperstimulation syndrome, pregnancy, reproductive health, reproductive medicine

Ferring Pharmaceuticals has reported that a conventional 15µg/day starting dose of follitropin delta (Rekovelle) provides comparable efficacy and safety to …

IVF image

‘Three-person’ IVF consultation

June 28, 2013
Research and Development, Sales and Marketing DoH, HFEA, IVF

The Department of Health is to publish draft guidelines later this year on a controversial IVF-based technique which would lead …

The Gateway to Local Adoption Series

Latest content